Complementing DepMap: Expanding the toolkit for oncology target discovery and de-risking - Pharmaceutical Technology

New tools are building on DepMap's foundations to help innovative companies identify hidden clinical positioning opportunities in competitive spaces. The Cancer Dependency Map and the Open Targets Platform provide a strong foundation for discovering new therapeutic targets for ground-breaking precision medicines based on the genetic mutations that drive disease. Now, new tools are building on this foundation to help innovative companies identify hidden clinical positioning opportunities in competitive spaces. With cancer responsible for one in six deaths around the world, precision medicines based on the root cause of the disease, genetic mutations, are vital. Developing these targeted therapies depends on…

Source: Pharmaceutical Technology